Back to Search
Start Over
R&D News from EULAR.
- Source :
-
Inpharma Weekly . 6/23/2007, Issue 1593, p7-7. 3/4p. - Publication Year :
- 2007
-
Abstract
- The article focuses on several studies presented at the 2007 Annual European Congress of Rheumatology (EULAR). One-year results from a phase II trial suggested the potential of golimumab for the treatment of rheumatoid arthritis (RA). Results from an extension of a randomized phase II study showed that belimumab is associated with durable benefits in patients with systemic lupus erythematosus. Denosumab therapy prevents bone erosion in RA patients according to a study.
Details
- Language :
- English
- ISSN :
- 11738324
- Issue :
- 1593
- Database :
- Academic Search Index
- Journal :
- Inpharma Weekly
- Publication Type :
- Periodical
- Accession number :
- 25777990
- Full Text :
- https://doi.org/10.2165/00128413-200715930-00015